Inmune Bio, Inc.INMBEarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
Inmune Bio, Inc. is a clinical-stage biotechnology company focused on developing targeted immunotherapies to address unmet medical needs, including hard-to-treat hematologic malignancies, solid tumors, and neurodegenerative diseases such as Alzheimer's. Its lead product candidates modulate the innate immune system to improve patient outcomes across global key markets.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Xencor, Inc. | 9.60% | 1.9M | — | 2024-10-02 |
| Highbridge Capital Management, LLC | 6.60% | 1.5M | — | 2024-10-25 |